secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001824293-24-000159
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

GRI Bio increases at-the-market offering capacity to $322,468 after $3.6M already sold
--------------------------------------------------------------------------------

- On December 20, 2024, GRI Bio filed a prospectus supplement to increase shares issuable under its ATM agreement with H.C. Wainwright to up to $322,468.
- The company had previously sold approximately $3,604,683 of shares under the same Sales Agreement dated May 20, 2024.
- An opinion from Mintz, Levin law firm on the legality of the share issuance was attached as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000159/0001824293-24-000159-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000159/val-20241220.htm
  HTML page:      https://secwatch.observer/filing/0001824293-24-000159

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer